Literature DB >> 27908351

Pim1 Kinase Overexpression Enhances ckit+ Cardiac Stem Cell Cardiac Repair Following Myocardial Infarction in Swine.

Shathiyah Kulandavelu1, Vasileios Karantalis1, Julia Fritsch1, Konstantinos E Hatzistergos1, Viky Y Loescher1, Frederic McCall1, Bo Wang1, Luiza Bagno1, Samuel Golpanian1, Ariel Wolf1, Justin Grenet1, Adam Williams1, Aaron Kupin1, Aaron Rosenfeld1, Sadia Mohsin2, Mark A Sussman2, Azorides Morales3, Wayne Balkan4, Joshua M Hare5.   

Abstract

BACKGROUND: Pim1 kinase plays an important role in cell division, survival, and commitment of precursor cells towards a myocardial lineage, and overexpression of Pim1 in ckit+ cardiac stem cells (CSCs) enhances their cardioreparative properties.
OBJECTIVES: The authors sought to validate the effect of Pim1-modified CSCs in a translationally relevant large animal preclinical model of myocardial infarction (MI).
METHODS: Human cardiac stem cells (hCSCs, n = 10), hckit+ CSCs overexpressing Pim1 (Pim1+; n = 9), or placebo (n = 10) were delivered by intramyocardial injection to immunosuppressed Yorkshire swine (n = 29) 2 weeks after MI. Cardiac magnetic resonance and pressure volume loops were obtained before and after cell administration.
RESULTS: Whereas both hCSCs reduced MI size compared to placebo, Pim1+ cells produced a ∼3-fold greater decrease in scar mass at 8 weeks post-injection compared to hCSCs (-29.2 ± 2.7% vs. -8.4 ± 0.7%; p < 0.003). Pim1+ hCSCs also produced a 2-fold increase of viable mass compared to hCSCs at 8 weeks (113.7 ± 7.2% vs. 65.6 ± 6.8%; p <0.003), and a greater increase in regional contractility in both infarct and border zones (both p < 0.05). Both CSC types significantly increased ejection fraction at 4 weeks but this was only sustained in the Pim1+ group at 8 weeks compared to placebo. Both hCSC and Pim1+ hCSC treatment reduced afterload (p = 0.02 and p = 0.004, respectively). Mechanoenergetic recoupling was significantly greater in the Pim1+ hCSC group (p = 0.005).
CONCLUSIONS: Pim1 overexpression enhanced the effect of intramyocardial delivery of CSCs to infarcted porcine hearts. These findings provide a rationale for genetic modification of stem cells and consequent translation to clinical trials.
Copyright © 2016 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  heart failure; human cardiac progenitor cells; injection; pressure volume

Mesh:

Substances:

Year:  2016        PMID: 27908351      PMCID: PMC5223744          DOI: 10.1016/j.jacc.2016.09.925

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  40 in total

1.  Adult c-kit(pos) cardiac stem cells are necessary and sufficient for functional cardiac regeneration and repair.

Authors:  Georgina M Ellison; Carla Vicinanza; Andrew J Smith; Iolanda Aquila; Angelo Leone; Cheryl D Waring; Beverley J Henning; Giuliano Giuseppe Stirparo; Roberto Papait; Marzia Scarfò; Valter Agosti; Giuseppe Viglietto; Gianluigi Condorelli; Ciro Indolfi; Sergio Ottolenghi; Daniele Torella; Bernardo Nadal-Ginard
Journal:  Cell       Date:  2013-08-15       Impact factor: 41.582

2.  Bone marrow mesenchymal stem cells stimulate cardiac stem cell proliferation and differentiation.

Authors:  Konstantinos E Hatzistergos; Henry Quevedo; Behzad N Oskouei; Qinghua Hu; Gary S Feigenbaum; Irene S Margitich; Ramesh Mazhari; Andrew J Boyle; Juan P Zambrano; Jose E Rodriguez; Raul Dulce; Pradip M Pattany; David Valdes; Concepcion Revilla; Alan W Heldman; Ian McNiece; Joshua M Hare
Journal:  Circ Res       Date:  2010-07-29       Impact factor: 17.367

3.  Synergistic roles for Pim-1 and c-Myc in STAT3-mediated cell cycle progression and antiapoptosis.

Authors:  T Shirogane; T Fukada; J M Muller; D T Shima; M Hibi; T Hirano
Journal:  Immunity       Date:  1999-12       Impact factor: 31.745

4.  The effect of age on the efficacy of human mesenchymal stem cell transplantation after a myocardial infarction.

Authors:  Ming Fan; Wei Chen; Wei Liu; Guo-Qing Du; Shu-Lin Jiang; Wei-Chen Tian; Lu Sun; Ren-Ke Li; Hai Tian
Journal:  Rejuvenation Res       Date:  2010-08       Impact factor: 4.663

5.  Pim-1 kinase protects mitochondrial integrity in cardiomyocytes.

Authors:  Gwynngelle A Borillo; Matt Mason; Pearl Quijada; Mirko Völkers; Christopher Cottage; Michael McGregor; Shabana Din; Kimberlee Fischer; Natalie Gude; Daniele Avitabile; Steven Barlow; Roberto Alvarez; Silvia Truffa; Ross Whittaker; Matthew S Glassy; Asa B Gustafsson; Shigeki Miyamoto; Christopher C Glembotski; Roberta A Gottlieb; Joan Heller Brown; Mark A Sussman
Journal:  Circ Res       Date:  2010-03-04       Impact factor: 17.367

6.  Functional Effect of Pim1 Depends upon Intracellular Localization in Human Cardiac Progenitor Cells.

Authors:  Kaitlen Samse; Jacqueline Emathinger; Nirmala Hariharan; Pearl Quijada; Kelli Ilves; Mirko Völkers; Lucia Ormachea; Andrea De La Torre; Amabel M Orogo; Roberto Alvarez; Shabana Din; Sadia Mohsin; Megan Monsanto; Kimberlee M Fischer; Walter P Dembitsky; Åsa B Gustafsson; Mark A Sussman
Journal:  J Biol Chem       Date:  2015-04-16       Impact factor: 5.157

7.  Enhanced effect of combining human cardiac stem cells and bone marrow mesenchymal stem cells to reduce infarct size and to restore cardiac function after myocardial infarction.

Authors:  Adam R Williams; Konstantinos E Hatzistergos; Benjamin Addicott; Fred McCall; Decio Carvalho; Viky Suncion; Azorides R Morales; Jose Da Silva; Mark A Sussman; Alan W Heldman; Joshua M Hare
Journal:  Circulation       Date:  2012-12-05       Impact factor: 29.690

8.  Human cardiac progenitor cells engineered with Pim-I kinase enhance myocardial repair.

Authors:  Sadia Mohsin; Mohsin Khan; Haruhiro Toko; Brandi Bailey; Christopher T Cottage; Kathleen Wallach; Divya Nag; Andrew Lee; Sailay Siddiqi; Feng Lan; Kimberlee M Fischer; Natalie Gude; Pearl Quijada; Daniele Avitabile; Silvia Truffa; Brett Collins; Walter Dembitsky; Joseph C Wu; Mark A Sussman
Journal:  J Am Coll Cardiol       Date:  2012-07-26       Impact factor: 24.094

Review 9.  Rebuilding the Damaged Heart: Mesenchymal Stem Cells, Cell-Based Therapy, and Engineered Heart Tissue.

Authors:  Samuel Golpanian; Ariel Wolf; Konstantinos E Hatzistergos; Joshua M Hare
Journal:  Physiol Rev       Date:  2016-07       Impact factor: 37.312

10.  Intrinsic hypoxia sensitivity of the cytomegalovirus promoter.

Authors:  K Wendland; M Thielke; A Meisel; P Mergenthaler
Journal:  Cell Death Dis       Date:  2015-10-15       Impact factor: 8.469

View more
  34 in total

1.  Hypoxia Prevents Mitochondrial Dysfunction and Senescence in Human c-Kit+ Cardiac Progenitor Cells.

Authors:  Kelli I Korski; Dieter A Kubli; Bingyan J Wang; Farid G Khalafalla; Megan M Monsanto; Fareheh Firouzi; Oscar H Echeagaray; Taeyong Kim; Robert M Adamson; Walter P Dembitsky; Åsa B Gustafsson; Mark A Sussman
Journal:  Stem Cells       Date:  2019-01-30       Impact factor: 6.277

2.  BNIP3L/NIX and FUNDC1-mediated mitophagy is required for mitochondrial network remodeling during cardiac progenitor cell differentiation.

Authors:  Mark A Lampert; Amabel M Orogo; Rita H Najor; Babette C Hammerling; Leonardo J Leon; Bingyan J Wang; Taeyong Kim; Mark A Sussman; Åsa B Gustafsson
Journal:  Autophagy       Date:  2019-02-22       Impact factor: 16.016

Review 3.  Mesenchymal Stem Cell-Based Therapy for Cardiovascular Disease: Progress and Challenges.

Authors:  Luiza Bagno; Konstantinos E Hatzistergos; Wayne Balkan; Joshua M Hare
Journal:  Mol Ther       Date:  2018-05-25       Impact factor: 11.454

Review 4.  Future directions for therapeutic strategies in post-ischaemic vascularization: a position paper from European Society of Cardiology Working Group on Atherosclerosis and Vascular Biology.

Authors:  Andrea Caporali; Magnus Bäck; Mat J Daemen; Imo E Hoefer; Elizabeth A Jones; Esther Lutgens; Christian M Matter; Marie-Luce Bochaton-Piallat; Arndt F Siekmann; Judith C Sluimer; Sabine Steffens; José Tuñón; Cecile Vindis; Jolanda J Wentzel; Seppo Ylä-Herttuala; Paul C Evans
Journal:  Cardiovasc Res       Date:  2018-09-01       Impact factor: 10.787

5.  Concurrent Isolation of 3 Distinct Cardiac Stem Cell Populations From a Single Human Heart Biopsy.

Authors:  Megan M Monsanto; Kevin S White; Taeyong Kim; Bingyan J Wang; Kristina Fisher; Kelli Ilves; Farid G Khalafalla; Alexandria Casillas; Kathleen Broughton; Sadia Mohsin; Walter P Dembitsky; Mark A Sussman
Journal:  Circ Res       Date:  2017-04-26       Impact factor: 17.367

Review 6.  Chasing c-Kit through the heart: Taking a broader view.

Authors:  Natalie A Gude; Mark A Sussman
Journal:  Pharmacol Res       Date:  2017-06-13       Impact factor: 7.658

7.  After the storm: an objective appraisal of the efficacy of c-kit+ cardiac progenitor cells in preclinical models of heart disease.

Authors:  Roberto Bolli; Xian-Liang Tang; Yiru Guo; Qianghong Li
Journal:  Can J Physiol Pharmacol       Date:  2020-09-16       Impact factor: 2.273

Review 8.  Preclinical Studies of Stem Cell Therapy for Heart Disease.

Authors:  Bryon A Tompkins; Wayne Balkan; Johannes Winkler; Mariann Gyöngyösi; Georg Goliasch; Francisco Fernández-Avilés; Joshua M Hare
Journal:  Circ Res       Date:  2018-03-30       Impact factor: 17.367

Review 9.  Cardiac regenerative therapy: Many paths to repair.

Authors:  Natalie A Gude; Mark A Sussman
Journal:  Trends Cardiovasc Med       Date:  2019-09-02       Impact factor: 6.677

10.  Age-Related Impaired Efficacy of Bone Marrow Cell Therapy for Myocardial Infarction Reflects a Decrease in B Lymphocytes.

Authors:  Songtao An; Xiaoyin Wang; Melissa A Ruck; Hilda J Rodriguez; Dmitry S Kostyushev; Monika Varga; Emmy Luu; Ronak Derakhshandeh; Sergey V Suchkov; Scott C Kogan; Michelle L Hermiston; Matthew L Springer
Journal:  Mol Ther       Date:  2018-06-15       Impact factor: 11.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.